ATP13A3-DT
gene geneOn this page
Summary
ATP13A3-DT (ATP13A3 divergent transcript, HGNC:48570) is a long non-coding RNA gene on chromosome 3q29.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48570 |
| Approved symbol | ATP13A3-DT |
| Name | ATP13A3 divergent transcript |
| Location | 3q29 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000233058 |
| Ensembl biotype | lncRNA |
| Entrez | 401106 |
| RNAcentral | URS000075C0BA — lncRNA, 1141 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 14 lncRNA
ENST00000437597, ENST00000448892, ENST00000653684, ENST00000656823, ENST00000657621, ENST00000661941, ENST00000662856, ENST00000665891, ENST00000670064, ENST00000671306, ENST00000685672, ENST00000847430, ENST00000847431, ENST00000847432
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000437597 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001719344 | 194497938 | 194500180 |
| ENSE00003865140 | 194487146 | 194487172 |
| ENSE00003871147 | 194488599 | 194488726 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 79.56.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.5791 / max 68.5220, expressed in 968 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 40651 | 1.9802 | 876 |
| 40652 | 0.4585 | 146 |
| 40654 | 0.0900 | 24 |
| 40653 | 0.0504 | 26 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.56 | gold quality |
| cortical plate | UBERON:0005343 | 76.62 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.23 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.83 | gold quality |
| right lobe of liver | UBERON:0001114 | 74.47 | gold quality |
| cerebellum | UBERON:0002037 | 74.40 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.82 | gold quality |
| sural nerve | UBERON:0015488 | 73.68 | gold quality |
| hypothalamus | UBERON:0001898 | 73.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.76 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.75 | gold quality |
| right frontal lobe | UBERON:0002810 | 71.00 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 70.95 | gold quality |
| prefrontal cortex | UBERON:0000451 | 70.61 | gold quality |
| adenohypophysis | UBERON:0002196 | 70.53 | gold quality |
| pituitary gland | UBERON:0000007 | 69.86 | gold quality |
| right atrium auricular region | UBERON:0006631 | 69.84 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.73 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 69.57 | gold quality |
| cardiac atrium | UBERON:0002081 | 69.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.54 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 69.39 | gold quality |
| neocortex | UBERON:0001950 | 69.22 | gold quality |
| frontal cortex | UBERON:0001870 | 69.10 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 69.08 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 68.92 | gold quality |
| amygdala | UBERON:0001876 | 68.85 | gold quality |
| parotid gland | UBERON:0001831 | 68.67 | gold quality |
| liver | UBERON:0002107 | 68.67 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.72 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.